Skip to main content
Erschienen in: International Urogynecology Journal 1/2020

27.11.2018 | Original Article

Evaluation of COLIA1-1997 G/T polymorphism as a related factor to genital prolapse

verfasst von: Claudia Cristina Palos, Beatriz Ferreira Timm, Denise de Souza Paulo, Cesar Eduardo Fernandes, Ricardo Peres de Souto, Emerson Oliveira

Erschienen in: International Urogynecology Journal | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Pelvic organ prolapse has a multifactorial etiology. There is increasing evidence that genetic factors greatly impact its development. This study aimed to evaluate the possible relation of the collagenous polymorphism −1997 G/T with genital prolapse in Brazilian women.

Methods

A cohort study of 180 women with stage 0 or I (group A) pelvic organ prolapse disorder and 112 women with stage III or IV (group B) was conducted. Blood DNA was isolated, and the −1997 G/T polymorphism was identified by amplifying a region of the COLIA1 gene starting prior to the protein’s coding sequence.

Results

No significant difference in the prevalence of genotypes TG and TT was found between groups (p = 0.67); differences were not found even when patients were grouped by the presence of 0 or ≥ 1 polymorphic alleles (p = 0.46). Age and home birth were found to be independent risk factors for prolapse.

Conclusions

Our study could not find any association between the −1997G/T polymorphism and genital prolapse in Brazilian women.
Literatur
1.
Zurück zum Zitat Digesu GA, Chaliha C, Salvatore S, Hutchings A, Khullar V. The relationship of vaginal prolapse severity to symptoms and quality of life. BJOG. 2005;112(7):971–6.CrossRef Digesu GA, Chaliha C, Salvatore S, Hutchings A, Khullar V. The relationship of vaginal prolapse severity to symptoms and quality of life. BJOG. 2005;112(7):971–6.CrossRef
2.
Zurück zum Zitat Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89:501–6.CrossRef Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89:501–6.CrossRef
3.
Zurück zum Zitat Rodrigues AM, Girão MJ, da Silva ID, Sartori MG, Martins KF, Castro RA. COL1A1 Sp1-binding site polymorphism as a risk factor for genital prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:1471–5.CrossRef Rodrigues AM, Girão MJ, da Silva ID, Sartori MG, Martins KF, Castro RA. COL1A1 Sp1-binding site polymorphism as a risk factor for genital prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:1471–5.CrossRef
4.
Zurück zum Zitat Sioutis D, Economou E, Lambrinoudaki I, Tsamadias V, Creatsa M, Liapis A. Sp1 collagen I A1 polymorphism in women with stress urinary incontinence. Int Urogynecol J. 2011;22:835–9.CrossRef Sioutis D, Economou E, Lambrinoudaki I, Tsamadias V, Creatsa M, Liapis A. Sp1 collagen I A1 polymorphism in women with stress urinary incontinence. Int Urogynecol J. 2011;22:835–9.CrossRef
5.
Zurück zum Zitat Miedel A, Tegerstedt G, Mæhle-Schmidt M, Nyrén O, Hammarström M. Nonobstetric risk factors for symptomatic pelvic organ prolapse. Obstet Gynecol. 2009;113(15):1089–97.CrossRef Miedel A, Tegerstedt G, Mæhle-Schmidt M, Nyrén O, Hammarström M. Nonobstetric risk factors for symptomatic pelvic organ prolapse. Obstet Gynecol. 2009;113(15):1089–97.CrossRef
6.
Zurück zum Zitat Tegerstedt G, Miedel A, Mæhle-Schmidt M, Nyrén O, Hammarström M. Nonobstetric. Obstetric risk factors for symptomatic prolapse: a population-based approach. Am J Obstet Gynecol. 2009;194:75–81.CrossRef Tegerstedt G, Miedel A, Mæhle-Schmidt M, Nyrén O, Hammarström M. Nonobstetric. Obstetric risk factors for symptomatic prolapse: a population-based approach. Am J Obstet Gynecol. 2009;194:75–81.CrossRef
7.
Zurück zum Zitat Martins Kde F, de Jármy-DiBella ZI, da Fonseca AM, et al. Evaluation of demographic, clinical characteristics, and genetic polymorphism as risk factors for pelvic organ prolapse in Brazilian women. Neurourol Urodyn. 2011;30(7):1325–8.PubMed Martins Kde F, de Jármy-DiBella ZI, da Fonseca AM, et al. Evaluation of demographic, clinical characteristics, and genetic polymorphism as risk factors for pelvic organ prolapse in Brazilian women. Neurourol Urodyn. 2011;30(7):1325–8.PubMed
8.
Zurück zum Zitat Lammers K, Lince SL, Spath MA, et al. Pelvic organ prolapse and collagen-associated disorders. Int Urogynecol J. 2012;23:313–9.CrossRef Lammers K, Lince SL, Spath MA, et al. Pelvic organ prolapse and collagen-associated disorders. Int Urogynecol J. 2012;23:313–9.CrossRef
9.
Zurück zum Zitat Altman D, Forsman M, Falconer C, Lichtenstein L. Genetic influence on stress urinary incontinence and pelvic organ prolapse. Eur Urol. 2008;54(4):918–22.CrossRef Altman D, Forsman M, Falconer C, Lichtenstein L. Genetic influence on stress urinary incontinence and pelvic organ prolapse. Eur Urol. 2008;54(4):918–22.CrossRef
10.
Zurück zum Zitat Lince SL, van Kempen LCLT, Vierhout ME, Kluivers KB. A systematic review of clinical studies on hereditary factors in pelvic organ prolapse. Int Urogynecol J. 2012;23:1327–36.CrossRef Lince SL, van Kempen LCLT, Vierhout ME, Kluivers KB. A systematic review of clinical studies on hereditary factors in pelvic organ prolapse. Int Urogynecol J. 2012;23:1327–36.CrossRef
11.
Zurück zum Zitat Singh M, Singh P, Singh S, Juneja PK, Kaur T. A haplotype derived from the common variants at the 21997G/T and Sp1 binding site of the COL1A1 gene influences risk of postmenopausal osteoporosis in India. Rheumatol Int. 2013;33:501–6.CrossRef Singh M, Singh P, Singh S, Juneja PK, Kaur T. A haplotype derived from the common variants at the 21997G/T and Sp1 binding site of the COL1A1 gene influences risk of postmenopausal osteoporosis in India. Rheumatol Int. 2013;33:501–6.CrossRef
12.
Zurück zum Zitat Jin H, Evangelou E, Ioannidis JPA, Ralston SH. Polymorphisms in the 5′ flank of COL1A1 gene and osteoporosis: meta analysis of published studies. Osteoporos Int. 2011;22:911–21.CrossRef Jin H, Evangelou E, Ioannidis JPA, Ralston SH. Polymorphisms in the 5′ flank of COL1A1 gene and osteoporosis: meta analysis of published studies. Osteoporos Int. 2011;22:911–21.CrossRef
13.
Zurück zum Zitat Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P, Bailey AJ. Changes in metabolism of collagen in genitourinary prolapse. Lancet. 1996;347:1658–61.CrossRef Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P, Bailey AJ. Changes in metabolism of collagen in genitourinary prolapse. Lancet. 1996;347:1658–61.CrossRef
14.
Zurück zum Zitat Takano CC, Girão MJBC, Sartori MGF, et al. Analysis of collagen in parametrium and vaginal apex of women with and without uterine prolapse. Int Urogynecol J. 2002;13:342–5.CrossRef Takano CC, Girão MJBC, Sartori MGF, et al. Analysis of collagen in parametrium and vaginal apex of women with and without uterine prolapse. Int Urogynecol J. 2002;13:342–5.CrossRef
15.
Zurück zum Zitat Haylen BT, de Ridder D, Freeman RM, et al. An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20.PubMed Haylen BT, de Ridder D, Freeman RM, et al. An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20.PubMed
16.
Zurück zum Zitat Bortolini MAT, Rizk DEE. Genetics of pelvic organ prolapse: crossing the bridge between bench and bedside in urogynecologic research. Int Urogynecol J. 2011;22:1211–9.CrossRef Bortolini MAT, Rizk DEE. Genetics of pelvic organ prolapse: crossing the bridge between bench and bedside in urogynecologic research. Int Urogynecol J. 2011;22:1211–9.CrossRef
17.
Zurück zum Zitat Ward RM, Edwards DRV, Edwards T, Giri A, Jerome RN, WU JM. Genetic epidemiology of pelvic organ prolapse: a systematic review. Am J Obstet Gynecol. 2014;211(4):326–35.CrossRef Ward RM, Edwards DRV, Edwards T, Giri A, Jerome RN, WU JM. Genetic epidemiology of pelvic organ prolapse: a systematic review. Am J Obstet Gynecol. 2014;211(4):326–35.CrossRef
18.
Zurück zum Zitat Feiner B, Fares F, Azam N, Auslender R, David M, Abramov Y. Does COLIA1 SP1-binding site polymorphism predispose women to pelvic organ prolapse? Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(9):1061–5.CrossRef Feiner B, Fares F, Azam N, Auslender R, David M, Abramov Y. Does COLIA1 SP1-binding site polymorphism predispose women to pelvic organ prolapse? Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(9):1061–5.CrossRef
19.
Zurück zum Zitat Cho HJ, Jung HJ, Kim SK, Choi JR, Cho NH, Bai SW. Polymorphism of a COLIA1 gene Sp1 binding site in Korean women with pelvic organ prolapse. Yonsei Med J. 2009;50(4):564–8.CrossRef Cho HJ, Jung HJ, Kim SK, Choi JR, Cho NH, Bai SW. Polymorphism of a COLIA1 gene Sp1 binding site in Korean women with pelvic organ prolapse. Yonsei Med J. 2009;50(4):564–8.CrossRef
20.
Zurück zum Zitat Skorupski P, Miotła P, Jankiewicz K, Rechberger T. Polymorphism of the gene encoding alpha-1 chain of collagen type I and a risk of pelvic organ prolapse—a preliminary study. Ginekol Pol. 2007;78(11):852–5.PubMed Skorupski P, Miotła P, Jankiewicz K, Rechberger T. Polymorphism of the gene encoding alpha-1 chain of collagen type I and a risk of pelvic organ prolapse—a preliminary study. Ginekol Pol. 2007;78(11):852–5.PubMed
21.
Zurück zum Zitat Cartwright R, Kirby AC, Tikkinen KA, et al. Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women. Am J Obstet Gynecol. 2015;212(199):e1–24. Cartwright R, Kirby AC, Tikkinen KA, et al. Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women. Am J Obstet Gynecol. 2015;212(199):e1–24.
22.
Zurück zum Zitat Leng B, Zhou Q, Zuo M. Association of COL1A1 Sp1-binding site polymorphism with susceptibility to pelvic organ prolapse: a meta-analysis. Int J Clin Exp Med. 2016;9(2):580–7. Leng B, Zhou Q, Zuo M. Association of COL1A1 Sp1-binding site polymorphism with susceptibility to pelvic organ prolapse: a meta-analysis. Int J Clin Exp Med. 2016;9(2):580–7.
23.
Zurück zum Zitat Lee SW, Cho HH, Kim MR, et al. Association between pelvic organ prolapse and bone mineral density in postmenopausal women. J Obstet Gynaecol. 2015;35:476–80. Early Online: 1–5.CrossRef Lee SW, Cho HH, Kim MR, et al. Association between pelvic organ prolapse and bone mineral density in postmenopausal women. J Obstet Gynaecol. 2015;35:476–80. Early Online: 1–5.CrossRef
Metadaten
Titel
Evaluation of COLIA1-1997 G/T polymorphism as a related factor to genital prolapse
verfasst von
Claudia Cristina Palos
Beatriz Ferreira Timm
Denise de Souza Paulo
Cesar Eduardo Fernandes
Ricardo Peres de Souto
Emerson Oliveira
Publikationsdatum
27.11.2018
Verlag
Springer International Publishing
Erschienen in
International Urogynecology Journal / Ausgabe 1/2020
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-018-3833-x

Weitere Artikel der Ausgabe 1/2020

International Urogynecology Journal 1/2020 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Menopausale Hormontherapie für Frauen über 65?

07.05.2024 Klimakterium und Menopause Nachrichten

In den USA erhalten nicht wenige Frauen auch noch im Alter über 65 eine menopausale Hormontherapie. Welche positiven und negativen gesundheitlichen Konsequenzen daraus möglicherweise resultieren, wurde anhand von Versicherungsdaten analysiert.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.